RxDoctor Payments Data

John Partin

Family · Russell Springs, KYNPI 1750698734

Payments from drug & device makers

$1,199in general payments, 2019–2025

Across 69 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$213
  • AbbVie$199
  • AstraZeneca$172
  • Abbott$107
  • Novartis$88
  • Seqirus USA Inc$50
  • plus $371 from 14 others

What the payments were for

  • Food & beverage$1,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,199 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,374
Medicare patients
69
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$64,404
FarxigaDapagliflozin Propanediol78$58,165
MounjaroTirzepatide42$47,917
JardianceEmpagliflozin56$44,297
OzempicSemaglutide39$39,900
JanuviaSitagliptin Phosphate48$34,990
TrulicityDulaglutide21$23,643
Tresiba Flextouch U-100Insulin Degludec35$22,169
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$20,184
Repatha SureclickEvolocumab23$16,510
XareltoRivaroxaban20$15,213
TradjentaLinagliptin16$13,803
Spiriva HandihalerTiotropium Bromide18$12,983
RybelsusSemaglutide12$10,929
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$7,629

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$213$71,56063 claims
PfizerEliquis$32$64,40494 claims
AstraZenecaFarxiga$172$58,16578 claims
Novo NordiskOzempic, Rybelsus, Levemir$33$52,24163 claims
MerckJanuvia$19$34,99048 claims
GSKTrelegy Ellipta, Breo Ellipta$34$25,09141 claims
Johnson & JohnsonXarelto$16$15,21320 claims
AbbVieSynthroid$199$1,24026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Russell Springs

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →